Medicine and Dentistry
Surgery
100%
Overall Survival
45%
Neoplasm
45%
Recurrent Disease
34%
Pancreas Islet Cell Tumor
26%
Abdominal Cancer
26%
Cancer
24%
Lymph Node
21%
Cholangiocarcinoma
21%
Diseases
20%
Stomach Adenocarcinoma
18%
Recurrence Free Survival
18%
Connective Tissue Cancer
17%
Neuroendocrine Tumor
17%
Adrenal Cortex Carcinoma
15%
Malignant Neoplasm
14%
Gallbladder Cancer
13%
Hazard Ratio
13%
Pancreaticoduodenectomy
13%
Lymph Node Metastasis
12%
Liver Metastasis
11%
Soft Tissue Sarcoma
11%
Pancreas Adenocarcinoma
10%
Melanoma
10%
Hepatectomy
10%
Adjuvant Therapy
10%
Metastatic Carcinoma
9%
Radiation Therapy
9%
Long Term Survival
9%
Retroperitoneal Lymph Node Dissection
8%
Pancreas Cancer
8%
Odds Ratio
8%
Postoperative Complication
8%
Pancreatectomy
7%
Surgeon
7%
Adenocarcinoma
7%
Retroperitoneal Sarcoma
6%
Disease Free Survival
6%
Surgical Margin
6%
Merkel Cell Carcinoma
6%
Disease Specific Survival
6%
Cancer Surgery
6%
Colorectal Carcinoma
6%
Lymphovascular Invasion
5%
Blood Transfusion
5%
Neutrophil
5%
Distal Pancreatectomy
5%
Keyphrases
Resection
50%
Overall Survival
38%
Curative Resection
25%
Gastric Cancer
24%
Pancreatic Neuroendocrine Tumors (pNETs)
23%
Tumor
21%
Recurrence-free Survival
20%
Sarcoma
17%
Biliary Malignancy
17%
Gastric Adenocarcinoma
17%
Adrenocortical Carcinoma
15%
Hazard Ratio
15%
Lymph Node Metastasis
15%
Pancreatic Ductal Adenocarcinoma
14%
Gallbladder Cancer
14%
Confidence Interval
13%
Pancreatic Cancer
12%
United States
12%
Neuroendocrine Tumor
12%
Pancreaticoduodenectomy
12%
Melanoma
11%
Multi-institutional Study
11%
Neuroendocrine Tumor Liver Metastases
11%
Adjuvant Therapy
10%
Multi-institutional Analysis
10%
Multi-institutional
9%
Long-term Survival
9%
Surgical Resection
9%
Tumor Research
9%
Hilar Cholangiocarcinoma
8%
Tumor Size
8%
Nomogram
8%
Odds Ratio
7%
Pancreatectomy
7%
5-year Survival
7%
Lymph Node
7%
Lymph Node Ratio
7%
Retroperitoneal Sarcoma
6%
Non-associated
6%
Early Recurrence
6%
Postoperative Complications
6%
Curative Intent
6%
Disease-specific Survival
6%
Risk Factors
6%
Merkel Cell Carcinoma
6%
Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET)
6%
Multivariable
6%
Pancreas
6%
Disease-free Survival
6%
Soft Tissue Sarcoma
6%